bpc-157 human clinical trial This doesn't mean is side-effect-free. But it does add to the safety signal. Credit to @dr.kseniamiami for mentioning this study on our recent podcast recording last week which will be out What no one's telling you
Description
This binding enhances the activity of GTPase Drp1, resulting in mitochondrial fusion and fission imbalances, mitochondrial distribution abnormalities, and mitochondrial axonal transport defects
Dont miss these: The wrong kind of needle was use (U40 instead of U100)

Confirm appointment and complete your MEDICAL FORMS ONLINE using your favorite device

Everything I needed was included

Additionally, a 2025 retrospective study on chronic knee pain showed that 14 out of 16 patients reported significant relief lasting 612 months, and a 2024 pilot study on interstitial cystitis achieved symptom resolution in 10 out of 12 subjects

PMID: 40756949 Safety of Intravenous Infusion of BPC157 in Humans. 2025
